Literature DB >> 27234419

The Type of Growth Medium Affects the Presence of a Mycobacterial Capsule and Is Associated With Differences in Protective Efficacy of BCG Vaccination Against Mycobacterium tuberculosis.

Rafael Prados-Rosales1, Leandro J Carreño2, Brian Weinrick3, Ana Batista-Gonzalez4, Aarona Glatman-Freedman5, Jiayong Xu6, John Chan6, William R Jacobs3, Steven A Porcelli4, Arturo Casadevall7.   

Abstract

BACKGROUND: Bacillus Calmette-Guerin (BCG) vaccine is widely used for the prevention of tuberculosis, despite limited efficacy. Most immunological studies of BCG or Mycobacterium tuberculosis strains grow bacteria in the presence of detergent, which also strips the mycobacterial capsule. The impact of the capsule on vaccine efficacy has not been explored.
METHODS: We tested the influence of detergent in cultures of BCG and M. tuberculosis strains on the outcome of vaccination experiments on mice and transcriptional responses on M. tuberculosis
RESULTS: Vaccination of mice with encapsulated BCG promoted a more potent immune response relative to vaccination with unencapsulated BCG, including higher polysaccharide-specific capsule antibody titers, higher interferon γ and interleukin 17 splenic responses, and more multifunctional CD4(+) T cells. These differences correlated with variability in the bacterial burden in lung and spleen of mice infected with encapsulated or unencapsulated M. tuberculosis The combination of vaccination and challenge with encapsulated strains resulted in the greatest protection efficacy. The transcriptome of encapsulated M. tuberculosis was similar to that of starvation, hypoxia, stationary phase, or nonreplicating persistence.
CONCLUSIONS: The presence of detergent in growth media and a capsule on BCG were associated with differences in the outcome of vaccination, implying that these are important variables in immunological studies.
© The Author 2016. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail journals.permissions@oup.com.

Entities:  

Keywords:  BCG; Mycobacterium tuberculosis; capsule; vaccine

Mesh:

Substances:

Year:  2016        PMID: 27234419      PMCID: PMC4936643          DOI: 10.1093/infdis/jiw153

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  37 in total

1.  The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism: novel insights into drug mechanisms of action.

Authors:  Helena I M Boshoff; Timothy G Myers; Brent R Copp; Michael R McNeil; Michael A Wilson; Clifton E Barry
Journal:  J Biol Chem       Date:  2004-07-09       Impact factor: 5.157

2.  Differential Immune Responses and Protective Effects in Avirulent Mycobacterial Strains Vaccinated BALB/c Mice.

Authors:  Laicheng Liu; Ruiling Fu; Xuefeng Yuan; Chunwei Shi; Shuling Wang; Xianyu Lu; Zhao Ma; Xiaoming Zhang; Weiyan Qin; Xionglin Fan
Journal:  Curr Microbiol       Date:  2015-05-21       Impact factor: 2.188

3.  Regulation of the Mycobacterium tuberculosis hypoxic response gene encoding alpha -crystallin.

Authors:  D R Sherman; M Voskuil; D Schnappinger; R Liao; M I Harrell; G K Schoolnik
Journal:  Proc Natl Acad Sci U S A       Date:  2001-06-19       Impact factor: 11.205

4.  Monoclonal antibodies to surface antigens of Mycobacterium tuberculosis and their use in a modified enzyme-linked immunosorbent spot assay for detection of mycobacteria.

Authors:  A Glatman-Freedman; J M Martin; P F Riska; B R Bloom; A Casadevall
Journal:  J Clin Microbiol       Date:  1996-11       Impact factor: 5.948

5.  Mycobacteria release active membrane vesicles that modulate immune responses in a TLR2-dependent manner in mice.

Authors:  Rafael Prados-Rosales; Andres Baena; Luis R Martinez; Jose Luque-Garcia; Rainer Kalscheuer; Usha Veeraraghavan; Carmen Camara; Joshua D Nosanchuk; Gurdyal S Besra; Bing Chen; Juan Jimenez; Aharona Glatman-Freedman; William R Jacobs; Steven A Porcelli; Arturo Casadevall
Journal:  J Clin Invest       Date:  2011-04       Impact factor: 14.808

Review 6.  Development of the Mycobacterium bovis BCG vaccine: review of the historical and biochemical evidence for a genealogical tree.

Authors:  T Oettinger; M Jørgensen; A Ladefoged; K Hasløv; P Andersen
Journal:  Tuber Lung Dis       Date:  1999

7.  Direct visualization by cryo-EM of the mycobacterial capsular layer: a labile structure containing ESX-1-secreted proteins.

Authors:  Musa Sani; Edith N G Houben; Jeroen Geurtsen; Jason Pierson; Karin de Punder; Maaike van Zon; Brigitte Wever; Sander R Piersma; Connie R Jiménez; Mamadou Daffé; Ben J Appelmelk; Wilbert Bitter; Nicole van der Wel; Peter J Peters
Journal:  PLoS Pathog       Date:  2010-03-05       Impact factor: 6.823

8.  Mycobacterium tuberculosis gene expression during adaptation to stationary phase and low-oxygen dormancy.

Authors:  M I Voskuil; K C Visconti; G K Schoolnik
Journal:  Tuberculosis (Edinb)       Date:  2004       Impact factor: 3.131

9.  Does antibody to mycobacterial antigens, including lipoarabinomannan, limit dissemination in childhood tuberculosis?

Authors:  A M Costello; A Kumar; V Narayan; M S Akbar; S Ahmed; C Abou-Zeid; G A Rook; J Stanford; C Moreno
Journal:  Trans R Soc Trop Med Hyg       Date:  1992 Nov-Dec       Impact factor: 2.184

10.  A mycobacterial lipoarabinomannan specific monoclonal antibody and its F(ab') fragment prolong survival of mice infected with Mycobacterium tuberculosis.

Authors:  B Hamasur; M Haile; A Pawlowski; U Schroder; G Kallenius; S B Svenson
Journal:  Clin Exp Immunol       Date:  2004-10       Impact factor: 4.330

View more
  14 in total

Review 1.  The Mycobacterium tuberculosis capsule: a cell structure with key implications in pathogenesis.

Authors:  Rainer Kalscheuer; Ainhoa Palacios; Itxaso Anso; Javier Cifuente; Juan Anguita; William R Jacobs; Marcelo E Guerin; Rafael Prados-Rosales
Journal:  Biochem J       Date:  2019-07-18       Impact factor: 3.857

Review 2.  Esx Systems and the Mycobacterial Cell Envelope: What's the Connection?

Authors:  Rachel E Bosserman; Patricia A Champion
Journal:  J Bacteriol       Date:  2017-08-08       Impact factor: 3.490

3.  Retention of EsxA in the Capsule-Like Layer of Mycobacterium tuberculosis Is Associated with Cytotoxicity and Is Counteracted by Lung Surfactant.

Authors:  Johanna Raffetseder; Nino Iakobachvili; Vesa Loitto; Peter J Peters; Maria Lerm
Journal:  Infect Immun       Date:  2019-02-21       Impact factor: 3.441

4.  Reasons for optimism in the search for new vaccines for tuberculosis.

Authors:  T G Evans
Journal:  Epidemiol Infect       Date:  2017-04-17       Impact factor: 4.434

5.  Exposure to human alveolar lining fluid enhances Mycobacterium bovis BCG vaccine efficacy against Mycobacterium tuberculosis infection in a CD8+ T-cell-dependent manner.

Authors:  J I Moliva; A P Hossfeld; C H Canan; V Dwivedi; M D Wewers; G Beamer; J Turner; J B Torrelles
Journal:  Mucosal Immunol       Date:  2017-09-20       Impact factor: 7.313

6.  Differential Cultivation of Francisella tularensis Induces Changes in the Immune Response to and Protective Efficacy of Whole Cell-Based Inactivated Vaccines.

Authors:  Sudeep Kumar; Raju Sunagar; Giang Pham; Brian J Franz; Sarah J Rosa; Karsten R O Hazlett; Edmund J Gosselin
Journal:  Front Immunol       Date:  2017-01-10       Impact factor: 7.561

7.  RD5-mediated lack of PE_PGRS and PPE-MPTR export in BCG vaccine strains results in strong reduction of antigenic repertoire but little impact on protection.

Authors:  Louis S Ates; Fadel Sayes; Wafa Frigui; Roy Ummels; Merel P M Damen; Daria Bottai; Marcel A Behr; Jeroen W J van Heijst; Wilbert Bitter; Laleh Majlessi; Roland Brosch
Journal:  PLoS Pathog       Date:  2018-06-18       Impact factor: 6.823

Review 8.  The Humoral Immune Response to BCG Vaccination.

Authors:  Rachel Tanner; Bernardo Villarreal-Ramos; H Martin Vordermeier; Helen McShane
Journal:  Front Immunol       Date:  2019-06-11       Impact factor: 7.561

9.  Each Mycobacterium Requires a Specific Culture Medium Composition for Triggering an Optimized Immunomodulatory and Antitumoral Effect.

Authors:  Sandra Guallar-Garrido; Víctor Campo-Pérez; Alejandro Sánchez-Chardi; Marina Luquin; Esther Julián
Journal:  Microorganisms       Date:  2020-05-14

10.  The ESX-5 System of Pathogenic Mycobacteria Is Involved In Capsule Integrity and Virulence through Its Substrate PPE10.

Authors:  Louis S Ates; Aniek D van der Woude; Jovanka Bestebroer; Gunny van Stempvoort; René J P Musters; Juan J Garcia-Vallejo; Daisy I Picavet; Robert van de Weerd; Massimiliano Maletta; Coenraad P Kuijl; Nicole N van der Wel; Wilbert Bitter
Journal:  PLoS Pathog       Date:  2016-06-09       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.